Ausgabe 1/2014
Inhalt (11 Artikel)
Molecular Monitoring
Simona Soverini, Gianantonio Rosti, Michele Baccarani, Giovanni Martinelli
Maintaining Low BCR-ABL Signaling Output to Restrict CML Progression and Enable Persistence
Andreas Burchert
Immunology and Immunotherapy of Chronic Myeloid Leukemia
Mette Ilander, Can Hekim, Satu Mustjoki
PI3-Kinase Inhibitors in Chronic Lymphocytic Leukemia
Julie E. Chang, Brad S. Kahl
Bruton’s Tyrosine Kinase (BTK) Inhibitors in Clinical Trials
Jan A. Burger
Driving CAR-Based T-Cell Therapy to Success
Bipulendu Jena, Judy S. Moyes, Helen Huls, Laurence J. N. Cooper
Treatment of Older Patients with High-Risk Myelodysplastic Syndromes (MDS): The Emerging Role of Allogeneic Hematopoietic Stem Cell Transplantation (Allo HSCT)
Ehab Atallah, Kathryn Bylow, Jesse Troy, Wael Saber
Impact of the Affordable Care Act on Stem Cell Transplantation
Stephanie Farnia, Alicia Gedan, Michael Boo
Thinking Out of the Box—New Approaches to Controlling GVHD
Frédéric Baron, Stéphanie Humblet-Baron, Grégory Ehx, Sophie Servais, Muriel Hannon, Ludovic Belle, Chantal Lechanteur, Alexandra Briquet, Olivier Giet, Etienne Baudoux, Evelyne Willems, Yves Beguin
Clostridium difficile: Deleterious Impact on Hematopoietic Stem Cell Transplantation
Alejandro Callejas-Díaz, Juan C. Gea-Banacloche